| # | Drug | Count |
|---|---|---|
| 0 | INSULIN GLARGINE | 8954 |
| 1 | INSULIN LISPRO | 5630 |
| 2 | ADALIMUMAB | 4883 |
| 3 | ERGOCALCIFEROL | 4162 |
| 4 | PREDNISONE | 3925 |
| 5 | DUPILUMAB | 3858 |
| 6 | ASPIRIN | 3669 |
| 7 | ETANERCEPT | 3519 |
| 8 | ASPIRIN 81 MG | 3509 |
| 9 | ASPIRIN 325 MG | 3506 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRICLOSAN | 201 | 0.3484 |
| 1 | ACECLIDINE | 248 | 0.3374 |
| 2 | ESTRIOL | 394 | 0.2149 |
| 3 | ERGOCALCIFEROL | 4162 | 0.1400 |
| 4 | CLEAR MINT, GEL TOOTHPASTE | 134 | 0.1222 |
| 5 | SODIUM FLUORIDE F18 | 134 | 0.1213 |
| 6 | SODIUM FLUORIDE F-18 | 134 | 0.1209 |
| 7 | FARICIMAB | 856 | 0.0965 |
| 8 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 107 | 0.0944 |
| 9 | GOLIMUMAB | 1164 | 0.0924 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 14325 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 9220 |
| 2 | Corticosteroid [EPC] | 9122 |
| 3 | Benzodiazepine [EPC] | 5349 |
| 4 | GLP-1 Receptor Agonist [EPC] | 5044 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 4565 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 4314 |
| 7 | Proton Pump Inhibitor [EPC] | 4252 |
| 8 | Interleukin-4 Receptor alpha Antagonist [EPC] | 3858 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 3803 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Disclosing Agent [EPC] | 3 | 0.1429 |
| 1 | Endoglycosidase [EPC] | 131 | 0.0707 |
| 2 | Semifluorinated Alkane [EPC] | 91 | 0.0391 |
| 3 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 587 | 0.0356 |
| 4 | Antiseptic [EPC] | 144 | 0.0330 |
| 5 | Insulin [EPC] | 1481 | 0.0319 |
| 6 | Insulin Analog [EPC] | 14325 | 0.0319 |
| 7 | Carbonic Anhydrase Inhibitor [EPC] | 522 | 0.0258 |
| 8 | Cyclooxygenase Inhibitor [EPC] | 2 | 0.0244 |
| 9 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 330 | 0.0238 |